Medicare Enrolled
Dr. Nikki Neubauer, M.D.
Gynecologic Oncology Physician · Oak Lawn, IL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Neubauer from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Neubauer?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Neubauer
Dr. Nikki Neubauer is a gynecologic oncology physician in Oak Lawn, IL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Neubauer performed 20,586 Medicare services across 1,006 unique beneficiaries.
Between the years covered by Open Payments, Dr. Neubauer received a total of $835 from 15 pharmaceutical and/or device companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in gynecologic oncology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Neubauer is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 10% volume in IL
$835 industry payments
Medicare Practice Summary
Medicare Utilization ↗20,586
Medicare services
Top 10% in IL for gynecologic oncology physician
1,006
Unique beneficiaries
$24
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~1,083 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 7,956 | $0 | $2 |
| Pembrolizumab injection (Keytruda) | 4,600 | $41 | $146 |
| Bevacizumab injection, 10 mg Administration of a 10 mg dose of bevacizumab medication via injection. |
2,077 | $56 | $214 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
1,902 | $0 | $2 |
| Anti-nausea injection (Aloxi/palonosetron) | 790 | $1 | $122 |
| Pegfilgrastim injection, 0.5 mg An injection of pegfilgrastim, a medication that stimulates the production of white blood cells. This specific code applies to the brand-name drug and excludes biosimilar versions. |
612 | $76 | $1,444 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
426 | $2 | $300 |
| Anti-nausea injection (ondansetron/Zofran) | 424 | $0 | $4 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
287 | $93 | $400 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
179 | $13 | $105 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
177 | $145 | $530 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
172 | $23 | $152 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
168 | $106 | $686 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
166 | $1 | $6 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
87 | $53 | $334 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
60 | $23 | $156 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
59 | $129 | $620 |
| On-body injector for subcutaneous injection A device is applied to the skin to automatically deliver a medication injection under the skin. |
50 | $15 | $49 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
47 | $2 | $19 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
45 | $1 | $7 |
| Vaginoscopy An examination of the external female genitals using an endoscope. |
37 | $95 | $369 |
| Laparoscopic hysterectomy with salpingo-oophorectomy, 250g or less Surgical removal of the uterus, fallopian tubes, and/or ovaries through small abdominal incisions using a camera-guided instrument. The procedure is specified for cases where the removed tissue weighs 250 grams or less. |
34 | $773 | $3,006 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
34 | $59 | $270 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
31 | $1 | $9 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
28 | $20 | $111 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
24 | $99 | $380 |
| Endoscopic biopsy and removal of abdominal lymph nodes A procedure to examine and remove lymph nodes in the abdominal cavity using an endoscope. The endoscope allows the provider to access the area through a small incision. |
21 | $233 | $1,788 |
| Intraoperative lymph node imaging Imaging performed during surgery to visualize lymph nodes. |
21 | $139 | $424 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
20 | $137 | $750 |
| New patient office visit, complex (60-74 min) | 15 | $184 | $760 |
| Prolonged office E/M service, first 15 minutes This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service. |
13 | $27 | $69 |
| Vaginoscopy and cervicoscopy An examination of the vagina and cervix using a thin, lighted tube called an endoscope. |
12 | $105 | $385 |
| Endometrial biopsy A procedure to remove a small sample of tissue from the lining of the uterus for examination. |
12 | $84 | $353 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.3% high complexity
94.0% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$835
Total received (2018-2024)
Avg $119/year across 7 years
Bottom 30% in IL for gynecologic oncology physician
15
Companies
32
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$835 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$48
2023
$29
2022
$92
2021
$42
2020
$26
2019
$370
2018
$228
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Tempus AI, Inc
$25
AstraZeneca Pharmaceuticals LP
$23
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Intuitive Surgical, Inc.
$292
Merck Sharp & Dohme Corporation
$100
Genentech USA, Inc.
$81
AstraZeneca Pharmaceuticals LP
$62
Myriad Genetic Laboratories, Inc.
$52
GlaxoSmithKline, LLC.
$46
Seagen Inc.
$42
Clovis Oncology, Inc.
$26
TESARO, Inc.
$25
Tempus AI, Inc
$25
Eisai Inc.
$22
Amgen Inc.
$17
Daiichi Sankyo Inc.
$17
Mylan Institutional Inc.
$15
DySIS Medical, Inc.
$13
Top 3 companies account for 56.7% of all-time payments
Associated products mentioned in payments ›
Avastin · Da Vinci Surgical System · Fulphila · INJECTAFER · KEYTRUDA · LYNPARZA · Lenvima · MYRISK · Neulasta · PreciseTumor · Rubraca · TIVDAK · Ultra 2.0 · ZEJULA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Gynecologic oncology physicians within 10 mi
41
Per 100K population
0.8
County median income
$81,797
Nearest hospital
ADVOCATE CHRIST HOSPITAL & MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Neubauer is a mixed practice specialist, with above-average Medicare volume (top 10% in IL), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Neubauer experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Neubauer performed 7,956 paclitaxel chemotherapy injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Neubauer receive payments from pharmaceutical companies?
Yes. Dr. Neubauer received a total of $835 from 15 companies across 32 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Neubauer's costs compare to other gynecologic oncology physicians in Oak Lawn?
Dr. Neubauer's average Medicare payment per service is $24. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Neubauer) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Gynecologic Oncology Physicians in Oak Lawn
Browse gynecologic oncology physicians in Oak Lawn ranked by procedure volume and transparency data.
Highest volume
Top Gynecologic Oncology Physicians in IL
Gynecologic oncology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Gynecologic Oncology Physicians in IL
Which IL gynecologic oncology physicians receive the most from drug and device companies.
By company
Intuitive Surgical, Inc. Payments to Doctors
See all physicians who received payments from Intuitive Surgical, Inc.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology